ZInvestorHunting

Adam E. Fine

Solo GP · New York, New York

Verified Active Check-WriterUS Angel

Named as the only individual (Managing Member of General Partner) on the Form D for Windham Life Sciences Partners IV, L.P., a $150M venture fund (Nov 2025). Also a non-executive director at 2 startups that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

83/ 100
High Conviction AngelActive in last 12 months
Deal VelocityActive in last 12 monthsUSA & Europe pipeline
Typical Check$1.5M–$4.5MPre-Seed / Seed
Primary FocusHealthcare, Biotech & PharmaSeed, Series A
Direct AccessWarm Intro Recommended1-click pitch match

Why Adam E. Fine holds a 83/100 confidence score

  • Verified active check-writing activity within the last 12 months
  • Target check sizes calibrated between $1.5M–$4.5M
  • Clear domain thesis in Healthcare, Biotech & Pharma
  • Named as the only individual (Managing Member of General Partner) on the Form D for Windham Life Sciences Partners IV, L.P., a $150M venture fund (Nov 2025). Also a non-executive director at 2 startups that filed Form D.

Building in Healthcare, Biotech & Pharma? See how well your pitch deck matches Adam E. Fine’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Managing Member of General Partner) on the Form D for Windham Life Sciences Partners IV, L.P., a $150M venture fund (Nov 2025). Also a non-executive director at 2 startups that filed Form D.

Source: SEC Form D: Windham Life Sciences Partners IV, L.P. (Nov 13, 2025) · 2 more sources

Stages
Seed, Series A
Typical check (est.)
$1.5M–$4.5M
Verified deals
3 on file
Latest activity
Nov 2025
Pitch Readiness

Is Adam E. Fine a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Adam E. Fine back?

HealthcareBiotech & Pharma

Verified investments & deal activity

3 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • RxWare

    Board seat on the company's SEC filing · DE

    May 2024
  • Valera Health

    Board seat on the company's SEC filing · NY

    Apr 2024
  • Windham Life Sciences Partners IV, L.P.

    Invested through a fund

    Nov 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Adam E. Fine

Founders raising in health and bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
Adam Rosenwach

Solo GP · New York, NY

85/100
Active Jun 2026
Biotech & PharmaHealthcare
John Parker

Solo GP · Sudbury, MA

86/100
$200K–$600KActive Nov 2025
HealthcareBiotech & Pharma
Matthew Hellauer

Solo GP · Baltimore, MD

87/100
Active Jun 2026
HealthcareBiotech & Pharma
Suzanne Fletcher

Solo GP · Portola Valley, CA

86/100
$300K–$900KActive Mar 2026
HealthcareAI & MLFintech+1
Patrick Gallagher

Syndicate lead · Austin, TX

90/100
$165K–$2.25MActive Aug 2026
Biotech & PharmaHealthcare
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Adam E. Fine and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.